M&T Bank
ROIV icon

M&T Bank’s Roivant Sciences ROIV Stock Holding History

M&T Bank’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$703K Buy
19,218
+2,305
+14% +$83.6K ﹤0.01% 1036
2026
Q2 		$599K Buy
16,913
+587
+4% +$17.3K ﹤0.01% 1121
2026
Q1 		$453K Buy
16,326
+3,036
+23% +$78K ﹤0.01% 1177
2025
Q4 		$288K Buy
+13,290
New +$262K ﹤0.01% 1415
2025
Q3 		– Sell
-12,802
Closed -$144K – 1587
2025
Q2 		$144K Buy
12,802
+1,181
+10% +$12.8K ﹤0.01% 1475
2025
Q1 		$117K Sell
11,621
-1,573
-12% -$17K ﹤0.01% 1467
2024
Q4 		$156K Buy
13,194
+1,851
+16% +$21.9K ﹤0.01% 1551
2024
Q3 		$131K Buy
+11,343
New +$129K ﹤0.01% 1549

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

M&T Bank's ROIV Position: Q3 2026 in Review

M&T Bank increased its Roivant Sciences (ROIV) stake by 14% in Q3 2026, buying an estimated $83.6K and bringing the position to 19,218 shares worth $703K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

M&T Bank first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. 244 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • M&T Bank held 19,218 shares of Roivant Sciences worth $703K as of Q3 2026.
  • M&T Bank bought 2,305 Roivant Sciences shares in Q3 2026, an estimated $83.6K.
  • Roivant Sciences made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1036 holding.
  • M&T Bank first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
  • 244 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.